Dr. Tresa Almy-albert, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Okatie Blvd. S, Ste 201, Okatie, SC 29909 Phone: 843-706-3206 |
Jenna Lee Sirmans, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Okatie Center Blvd S Ste 201, Okatie, SC 29909 Phone: 843-706-3206 Fax: 843-998-7667 |
Eric Stephen Peltz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Okatie Center Blvd. S., Suite 201, Okatie, SC 29909 Phone: 843-706-3206 Fax: 843-706-3226 |
Dr. Aimee Behnke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 719 Okatie Hwy # 170, Okatie, SC 29909 Phone: 843-987-7400 |
Alicia Avery Salyer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Okatie Center Blvd S, Suite 201, Okatie, SC 29909 Phone: 843-706-3206 Fax: 843-706-3226 |
Lance Steven Lowe, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Okatie Center Blvd S., Suite 201, Okatie, SC 29909 Phone: 843-706-3206 Fax: 843-706-3226 |
Annette Nimmer Thomas, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Okatie Center Blvd. S., Suite 201, Okatie, SC 29909 Phone: 843-706-3206 Fax: 843-706-3226 |
News Archive
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that the company raised $35.5 million in a Series E financing based on encouraging clinical progress and investor support for galeterone (TOK-001), Tokai's lead prostate cancer drug candidate.
Scientists are making strides in understanding how the malaria parasite Plasmodium falciparum disguises itself to avoid detection by the immune system. The findings could lead to the development of new drugs for a disease that causes more than 300 million acute illnesses and at least one million deaths each year, most of them in developing countries.
Blood transfusions used to treat anemia in patients with cancer are associated with an increased risk of life-threatening blood clots, at a similar rate as other treatments for cancer-induced anemia, according to scientists at the University of Rochester Medical Center.
Medicare allowed $1.7 billion in payments to laboratories in 2010 for claims that raised red flags, according to a report by the Department of Health and Human Services' Office of Inspector General.
At least a quarter of patients who have suffered a stroke stop taking one or more of their prescribed stroke prevention medications within the first three months after being hospitalized - when the chance of having another stroke is highest - according to a new study by researchers at Wake Forest University Baptist Medical Center and colleagues.
› Verified 9 days ago